[Microsatellite instability and therapeutic sensitivity]

Area of Science:

• Oncology
• Genetics
• Cancer Biology

Context:

• Colorectal tumors are classified as microsatellite stable (MSS) or microsatellite instable (MSI-H) based on genetic instability.
• MSI-H tumors arise from a defective mismatch repair (MMR) system and exhibit distinct characteristics, including proximal colon location, moderate to weak differentiation, mucinous features, tumor-infiltrating lymphocytes (TILs), and increased apoptosis.
• Patients with MSI-H colorectal tumors generally have a better prognosis than those with MSS tumors.

Purpose:

• To investigate the efficacy of adjuvant 5-fluorouracil (5FU) chemotherapy in patients with microsatellite instable (MSI-H) colorectal cancer.
• To clarify the discrepancy between the in vitro resistance of MSI-H colorectal cell lines to 5FU and the reported clinical benefits in some patient studies.

Summary:

• Cultured MSI-H colorectal cell lines demonstrate resistance to 5FU due to their defective MMR system, which impairs the repair of 5FU-induced DNA damage.
• While 5FU significantly impacts survival in MSS colorectal tumors, its benefit for MSI-H tumors remains controversial.
• This study presents evidence suggesting that previous findings of 5FU benefit in MSI-H colorectal tumors are based on flawed statistical analyses, indicating a lack of benefit from this chemotherapy in MSI-H patients.

Impact:

• The findings challenge the current understanding of 5FU efficacy in colorectal cancer treatment, particularly for the MSI-H subtype.
• This research may lead to revised treatment guidelines, potentially sparing MSI-H patients from ineffective and toxic chemotherapy.
• Highlights the critical importance of accurate statistical methodology in clinical trial interpretation and patient stratification.